跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
APO-AMOXI FOR ORAL SUSPENSION 125 MG/5 ML
Approved
THERAPEUTIC
APO-AMOXI FOR ORAL SUSPENSION 125 MG/5 ML
APO-BIOTICS LIMITED (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 7, 1988
Approval ID
c1ba7289f30dcaa5
Company
APO-BIOTICS LIMITED (CANADA)
Type
Therapeutic
Approval Details
Approval Id
c1ba7289f30dcaa5
Drug Name
APO-AMOXI FOR ORAL SUSPENSION 125 MG/5 ML
Product Name
APO-AMOXI FOR ORAL SUSPENSION 125 MG/5 ML
Approval Number
SIN01664P
Approval Date
1988-06-07
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01CA04
Atc Item Name
amoxicillin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
125 mg/5 ml
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
125 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 7, 1988
Approval ID
c1ba7289f30dcaa5
Type
Therapeutic
Back to HSA Approvals
APO-AMOXI FOR ORAL SUSPENSION 125 MG/5 ML - HSA Drug Approval Details